24-APR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1131 21 1096 112 1364 226 1376
ERLYTX 79 3 157 10 122 20 122
GI 179 4 209 15 183 29 177
GU 364 3 157 20 244 50 304
LEUK 148 3 157 15 183 25 152
LUNG 199 1 52 18 219 38 231
LYMPH 404 11 574 48 584 78 475
MELAN 166 0 0 0 0 0 0
MMYEL 113 2 104 17 207 26 158
MULT 38 2 104 11 134 15 91
OTHER 53 0 0 7 85 13 79
SXQOL 1 0 0 0 0 0 0
Total 2875 50 2610 273 3325 520 3165

24-APR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 149 3 157 20 244 35 213
ERLYTX 11 1 52 3 37 3 18
GU 3 0 0 2 24 3 18
LEUK 622 11 574 56 682 105 639
LUNG 371 4 209 34 414 73 444
OTHER 34 0 0 2 24 3 18
PEOLC 113 0 0 1 12 7 43
PREV 218 3 157 23 280 38 231
SXQOL 596 8 417 60 731 124 755
Total 2117 30 1566 201 2448 391 2379

24-APR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1131 21 1096 112 1364 226 1376
CCD 149 3 157 20 244 35 213
ERLYTX 90 4 209 13 158 23 140
GI 179 4 209 15 183 29 177
GU 367 3 157 22 268 53 323
LEUK 770 14 730 71 864 130 791
LUNG 570 5 261 52 633 111 676
LYMPH 404 11 574 48 584 78 475
MELAN 166 0 0 0 0 0 0
MMYEL 113 2 104 17 207 26 158
MULT 38 2 104 11 134 15 91
OTHER 87 0 0 9 110 16 97
PEOLC 113 0 0 1 12 7 43
PREV 218 3 157 23 280 38 231
SXQOL 597 8 417 60 731 124 755
Total 4992 80 4175 474 5772 911 5546

24-APR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 714 9 470 62 755 129 785
ERLYTX 47 2 104 8 97 13 79
GI 132 3 157 12 146 25 152
GU 290 3 157 13 158 37 225
LEUK 91 1 52 9 110 16 97
LUNG 124 0 0 8 97 24 146
LYMPH 263 6 313 25 304 49 298
MELAN 109 0 0 0 0 0 0
MMYEL 69 0 0 11 134 16 97
MULT 15 0 0 5 61 7 43
OTHER 53 0 0 7 85 13 79
SXQOL 1 0 0 0 0 0 0
Total 1908 24 1253 160 1947 329 2001

24-APR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 125 2 104 13 158 25 152
ERLYTX 11 1 52 3 37 3 18
GU 3 0 0 2 24 3 18
LEUK 267 5 261 24 292 45 274
LUNG 228 2 104 19 231 39 237
OTHER 34 0 0 2 24 3 18
PEOLC 82 0 0 1 12 5 30
PREV 218 3 157 23 280 38 231
SXQOL 425 5 261 42 511 96 584
Total 1393 18 939 129 1569 257 1562

24-APR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 891 11 574 72 877 157 956
CCD 155 1 52 17 207 33 201
ERLYTX 58 3 157 11 134 16 97
GI 138 3 157 15 183 28 170
GU 325 2 104 21 256 49 298
LEUK 359 6 313 33 402 62 377
LUNG 369 3 157 33 402 74 450
LYMPH 263 6 313 25 304 49 298
MELAN 109 0 0 0 0 0 0
MMYEL 69 0 0 11 134 16 97
MULT 37 0 0 2 24 7 43
OTHER 230 0 0 10 122 32 195
PEOLC 80 1 52 1 12 6 37
PREV 218 3 157 23 280 38 231
SXQOL 426 5 261 42 511 96 584
Total 3727 44 2297 316 3848 663 4034

24-APR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 948 18 939 101 1230 204 1242
ERLYTX 73 3 157 8 97 17 103
GI 103 1 52 7 85 15 91
GU 228 3 157 19 231 34 207
LEUK 114 3 157 12 146 21 128
LUNG 165 1 52 18 219 35 213
LYMPH 333 9 470 41 499 66 402
MMYEL 99 2 104 15 183 24 146
MULT 38 2 104 11 134 15 91
Total 2101 42 2192 232 2824 431 2623

24-APR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1940 25 1304 166 2021 347 2112
AFFIL 133 1 52 11 134 17 103
CCOP/NCORP 1228 16 835 112 1364 222 1351
Non-SWOG 1687 34 1774 181 2204 321 1954
Total 4988 76 3965 470 5723 907 5520

24-APR-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GU S2419 Renal, adv clear cell, IO +/- Biotx, BIOFRONT 1 Y 22-APR-26

24-APR-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK EA9181 ALL, BCR-ABL+, Steroids+TKI+CT/Blinatumomab 0 E 26-MAR-26
LEUK EA9181 ALL, BCR-ABL+, Steroids+TKI+CT/Blinatumomab 1 E 26-MAR-26
LEUK EA9181 ALL, BCR-ABL+, Steroids+TKI+CT/Blinatumomab 2 E 26-MAR-26
LEUK EA9181 ALL, BCR-ABL+, Steroids+TKI+CT/Blinatumomab 3 E 26-MAR-26
GU NRGGU011 Pros, Dbl Blinded RT +/- Androgen Dep Tx 1 E 25-MAR-26
GU NRGGU008 Pros,Node+, Abiraterone acetate + Apalutamide 1 E 15-APR-26
BREAST NRGBR007 Breast, Stg I, De-Escalation of Breast RT 1 E 08-APR-26
BREAST NRGBR007 Breast, Stg I, De-Escalation of Breast RT 2 E 08-APR-26

24-APR-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 14
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 11
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 11
LUNG LUNGMAP NSCLC, Adv, Master 2 9
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 6
LUNG LUNGMAP NSCLC, Adv, Master 1 4
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 4
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 4
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 2 3
LEUK S1925 CLL/SLL, Newly Dx HR, Early vs Delayed V+O 1 3
ERLYTX S2012 Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo 1 3
LYMPH S2114 NHL, Rel/Ref, CD19 CAR-T +/- Consolidation 1 3